Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Alliance Grants

University of Western Ontario

$25,000.00

Characterization of the role of AKT1 in glucose metabolism

EF 2022-23

Résumé
Protein kinase B (AKT1) is a serine/threonine kinase that plays a central role in regulating cell survival pathways. AKT1 is inactive in its unphosphorylated form, requiring induced phosphorylation to investigate AKT1 biology. Typical approaches to study AKT1 biology in cells rely on unspecific growth factor or insulin stimulation that activates AKT1 via phosphorylation. A significant drawback of this stimulation lies in the lack of specificity, where many other kinases and pathways are activated at the same time. We therefore developed a novel system to deliver active AKT1 to human cells, circumventing the use of unspecific stimulation. We previously established a method to produce AKT1 phospho-variants from Escherichia coli with programmed phosphorylation. These AKT1 variants were fused with a cell penetrating peptide tag, allowing a direct uptake of pre-activated AKT1 to the cells using the cells very own protein import systems. This new method allows us to investigate AKT1 biology without using unspecific cell stimulation.In preliminary data, we showed that pre-activated TAT-phosphoAKT1 induced selective phosphorylation of the known AKT1 substrate glycogen synthase kinase 3a indicating a highly specific role for AKT in glucose metabolism. We will now investigate whether these changes are reflected on the metabolome level. Metabolites are small chemicals, such as the sugar glucose, that are converted into e.g. energy. Investigating the metabolome in response to AKT signalling will allow us to define the chemical footprints of AKT activated cells. Our collaboration with a world expert in metabolomics will uncover how cellular metabolism is regulated by AKT. While metabolomics is of increasing interest, very few researchers in Canada are able to apply this technique, and access to the required mass spectrometry equipment is limited. Adding metabolomics as another dimension to AKT signaling research is a unique opportunity for Canadian leadership in the endeavour broaden our knowledge on AKT1 biology.
Programme
Alliance Grants
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
580214-2022
Name nom
Heinemann, Ilka IU
Department département
Biochemistry
Organization id
36
Institution établissement
University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2022
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
5408
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Metabolism
Research subject fr
Métabolisme
Installment
inst:1
Partie
1
Nb partie
1
Application title
Characterization of the role of AKT1 in glucose metabolism
Application summary
Protein kinase B (AKT1) is a serine/threonine kinase that plays a central role in regulating cell survival pathways. AKT1 is inactive in its unphosphorylated form, requiring induced phosphorylation to investigate AKT1 biology. Typical approaches to study AKT1 biology in cells rely on unspecific growth factor or insulin stimulation that activates AKT1 via phosphorylation. A significant drawback of this stimulation lies in the lack of specificity, where many other kinases and pathways are activated at the same time. We therefore developed a novel system to deliver active AKT1 to human cells, circumventing the use of unspecific stimulation. We previously established a method to produce AKT1 phospho-variants from Escherichia coli with programmed phosphorylation. These AKT1 variants were fused with a cell penetrating peptide tag, allowing a direct uptake of pre-activated AKT1 to the cells using the cells very own protein import systems. This new method allows us to investigate AKT1 biology without using unspecific cell stimulation.In preliminary data, we showed that pre-activated TAT-phosphoAKT1 induced selective phosphorylation of the known AKT1 substrate glycogen synthase kinase 3a indicating a highly specific role for AKT in glucose metabolism. We will now investigate whether these changes are reflected on the metabolome level. Metabolites are small chemicals, such as the sugar glucose, that are converted into e.g. energy. Investigating the metabolome in response to AKT signalling will allow us to define the chemical footprints of AKT activated cells. Our collaboration with a world expert in metabolomics will uncover how cellular metabolism is regulated by AKT. While metabolomics is of increasing interest, very few researchers in Canada are able to apply this technique, and access to the required mass spectrometry equipment is limited. Adding metabolomics as another dimension to AKT signaling research is a unique opportunity for Canadian leadership in the endeavour broaden our knowledge on AKT1 biology.